(Q39531883)

12 September 2017

1 reference

title

Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity (English)

1 reference

12 September 2017

0 references

Hiserodt JC

1

1 reference

PubMed ID

3052213

12 September 2017

Chambers WH

series ordinal

2

1 reference

PubMed ID

3052213

12 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Annals of the New York Academy of Sciences

12 September 2017

1 reference

12 September 2017

532

1 reference

12 September 2017

395-404

1 reference

An endotoxin-induced serum factor that causes necrosis of tumors

12 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Partial purification of a serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Mediation of mouse natural cytotoxic activity by tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Polarization of the Golgi apparatus and the microtubule-organizing center within cloned natural killer cells bound to their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Lymphokine-activated killer cells. Analysis of progenitors and effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Natural cytotoxic cells against solid tumors in mice: blocking of cytotoxicity by D-mannose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Mannose 6-, fructose 1-, and fructose 6-phosphates inhibit human natural cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Recycling and target binding capacity of human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB36357.X

10.1111/J.1749-6632.1988.TB36357.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

3052213